Economic impact of rapid diagnostic methods in Clinical Microbiology: Price of the test or overall clinical impact

Patel, 2016, New developments in clinical bacteriology laboratories, Mayo Clin Proc, 91, 1448, 10.1016/j.mayocp.2016.06.020 Fournier, 2013, Modern clinical microbiology: new challenges and solutions, Nat Rev Microbiol, 11, 574, 10.1038/nrmicro3068 Drancourt, 2016, The point-of-care laboratory in Clinical Microbiology, Clin Microbiol Rev, 29, 429, 10.1128/CMR.00090-15 Estem, 2016, HIV Self-Testing: a review of current implementation and fidelity, Curr HIV/AIDS Rep, 13, 107, 10.1007/s11904-016-0307-y 2016 Buchan, 2014, Emerging technologies for the clinical microbiology laboratory, Clin Microbiol Rev, 27, 783, 10.1128/CMR.00003-14 Morel, 2016 Tenover, 2010, Potential impact of rapid diagnostic tests on improving antimicrobial use, Ann N Y Acad Sci, 1213, 70, 10.1111/j.1749-6632.2010.05827.x Dixon, 2015, A systematic review of matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry compared to routine microbiological methods for the time taken to identify microbial organisms from positive blood cultures, Eur J Clin Microbiol Infect Dis, 34, 863, 10.1007/s10096-015-2322-0 Zhang, 2015, Multiplex polymerase chain reaction tests for detection of pathogens associated with gastroenteritis, Clin Lab Med, 35, 461, 10.1016/j.cll.2015.02.006 Buehler, 2016, Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis, Clin Microbiol Rev, 29, 59, 10.1128/CMR.00053-14 Diekema, 2013, Rapid detection of antibiotic-resistant organism carriage for infection prevention, Clin Infect Dis, 56, 1614, 10.1093/cid/cit038 Caliendo, 2013, Better tests, better care: improved diagnostics for infectious diseases, Clin Infect Dis, 57, S139, 10.1093/cid/cit578 Seng, 2009, Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Clin Infect Dis, 49, 543, 10.1086/600885 Gómez, 2016, Estudios de coste efectividad con MALDI TOF e impacto clínico, Enferm Infecc Microbiol Clin, 34, 47, 10.1016/S0213-005X(16)30191-4 Desmet, 2016, Broad-range PCR coupled with electrospray ionization time of flight mass spectrometry for detection of bacteremia and fungemia in patients with neutropenic fever, J Clin Microbiol, 54, 2513, 10.1128/JCM.01066-16 Stevenson, 2016, Sepsis: The LightCycler SeptiFast Test MGRADE® SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi: a systematic review and economic evaluation, Health Technol Assess, 20, 1 Bouricha, 2014, Point-of-care syndrome-based, rapid diagnosis of infections on commercial ships, J Travel Med, 21, 12, 10.1111/jtm.12090 Clerc, 2010, Routine use of point-of-care tests: usefulness and application in clinical microbiology, Clin Microbiol Infect, 16, 1054, 10.1111/j.1469-0691.2010.03281.x Moore, 2013, Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line?, J Hosp Infect, 85, 1, 10.1016/j.jhin.2013.06.005 Brenwald, 2010, Feasibility study of a real-time PCR test for methicillin-resistant Staphylococcus aureus in a point of care setting, J Hosp Infect, 74, 245, 10.1016/j.jhin.2009.09.007 Goldenberg, 2014, Point-of-care testing for Clostridium difficile infection: a real-world feasibility study of a rapid molecular test in two hospital settings, Infect Dis Ther, 3, 295, 10.1007/s40121-014-0038-6 2011 Cohen-Bacrie, 2011, Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care, PLoS ONE, 6, 22403, 10.1371/journal.pone.0022403 Real Decreto Legislativo 1/2015, de 24 de julio, por el que se aprueba el texto refundido de la Ley de garantías y uso racional de los medicamentos y productos sanitarios. BOE núm. 177, 25 de julio de 2015; p. 62935–3030. Prieto, 2004, Análisis de coste-efectividad en la evaluación económica de intervenciones sanitarias, Med Clin (Barc), 122, 423, 10.1016/S0025-7753(04)74260-8 Zimlichman, 2013, Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system, JAMA Intern Med, 173, 2039, 10.1001/jamainternmed.2013.9763 Tansarli, 2013, Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence, Expert Rev Anti Infect Ther, 11, 321, 10.1586/eri.13.4 Gandra, 2014, Economic burden of antibiotic resistance: how much do we really know?, Clin Microbiol Infect, 20, 973, 10.1111/1469-0691.12798 Perez, 2013, Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs, Arch Pathol Lab Med, 137, 1247, 10.5858/arpa.2012-0651-OA Perez, 2014, Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia, J Infect, 69, 216, 10.1016/j.jinf.2014.05.005 Patel, 2016, Cost analysis of implementing matrix-assisted laser desorption ionization-time of flight mass spectrometry plus real-time antimicrobial stewardship intervention for bloodstream infections, J Clin Microbiol, 55, 60, 10.1128/JCM.01452-16 Bauer, 2014, Review of rapid diagnostic tests used by antimicrobial stewardship programs, Clin Infect Dis, 59, S134, 10.1093/cid/ciu547 McElvania TeKippe, 2016, The added cost of rapid diagnostic testing and active antimicrobial stewardship: is it worth it?, J Clin Microbiol, 55, 20, 10.1128/JCM.02061-16 Gómez, 2014, Estudio de coste-efectividad de la espectrometría de masas (MALDI TOF) para la identificación de Candida spp. al nivel de especie y la adecuación del tratamiento en pacientes cone candidemia, Gest Eval Cost Sanit, 15, 457 National Institute for Health and Care Excellence. Available from: http://www.nice.org.uk [accessed 12.9.17]. Real Decreto-ley 9/2011, de 19 de agosto, de medidas para la mejora de la calidad y cohesión del sistema nacional de salud, de contribución a la consolidación fiscal, y de elevación del importe máximo de los avales del Estado para 2011. BOE n.° 200, 20 de agosto de 2011; Sec. I: p. 93143–68. Cabiedes Miragaya, 2012 Reglamento (UE) 2017/746 del Parlamento Europeo y del Consejo de 5 de abril de 2017 sobre los productos sanitarios para diagnóstico in vitro y por el que se derogan la Directiva 98/79/CE y la Decisión 2010/227/UE de la Comisión.